Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Senores Pharmaceuticals IPO listing
Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees
According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ₹676
Senores Pharmaceuticals Share Price, IPO Listing Highlights: IPO lists at 53% premium, stock closes 6.3% lower
Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check listing price, GMP, and allotment now!
Senores Pharmaceuticals share price, IPO listing highlights:The IPO debuts with strong premium but shares end in red
The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the stock touched a 52-week high of ₹609.65 and a low of ₹538.85. Despite the dip,
Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price
Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock witnessed some profit taking at higher levels.
Senores Pharmaceuticals IPO Vs Ventive Hospitality IPO: Which issue will list with higher gains?
Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!
Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close
Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.
Senores Pharmaceuticals IPO allotment today: Key details investors need to know
The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024. Investors who subscribed to the public offering can check their allotment status on the official websites of BSE,
Senores Pharmaceuticals Listing: Shares debut strong with 53% premium over IPO price
The issue had opened for public subscription on December 20 to raise about ₹582 crore from the primary market.
Senores Pharmaceuticals Lists At Premium Of 53% Over IPO Price
The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.1 crore.
Senores Pharmaceuticals IPO makes a healthy debut on the exchange, lists at 53% premium
Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE,
ET Now on MSN
5d
Senores Pharmaceuticals IPO GMP today; allotment status date and time - check online guide, tutorial
Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of ...
ndtvprofit
2d
IPO GMP Today: Unimech Aerospace To Senores Pharmaceuticals - Which IPO Indicates Strong Listing Day Gains?
Carraro India, Senores Pharmaceuticals, and Ventive Hospitality will list on Monday, along with Unimech Aerospace and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Trump endorses Johnson
'Star Wars' actor dies
Faces new charges
Reveals cancer surgery
Cold case killer identified
Lego display collapses
New suspects in '96 case
Arrests in death of agent
Reach divorce settlement
Anchor Aaron Brown dies
Commutes death sentences
Lenny Randle dies
Smith drops docs appeal
Tugboat hits tanker, sinks
Woman set on fire identified
Appoints new prison leader
Near miss for Gonzaga plane
Indiana soldier dies in Iraq
Bowser meets with Trump
Congestion pricing ruling
NHL fines Stars $100K
Kwon extradited to US
DC US attorney to resign
Venezuela fines TikTok $10M
World leaders pay tribute
Ex-FSU players sue coach
9/11 plea deals can proceed
Bird flu in AZ wastewater
Pending home sales rise
Loses sentencing delay bid
US sanctions Russia, Iran
Signs deal with Ukraine
Final payout for victims
Feedback